diabetes mellitus, type 2
Showing NaN - NaN of 128
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Tuscumbia, Alabama
- +116 more
Feb 14, 2020
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathy
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +592 more
Dec 4, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Muscle Shoals, Alabama
- +142 more
Nov 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec/insulin aspart
- +2 more
-
Glendale, Arizona
- +70 more
Nov 8, 2019
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Insulin Glargine
-
Fresno, California
- +68 more
Sep 6, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Insulin
-
Huntington Beach, California
- +59 more
Sep 6, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Type 2, Diabetes Trial in Russian Federation (Humalog Mix25, Insulin Lispro Biphasic 25)
Completed
- Diabetes Mellitus, Type 2
- Diabetes Mellitus
- Humalog Mix25
- Insulin Lispro Biphasic 25
-
Chelyabinsk, Russian Federation
- +17 more
Jul 16, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Type 2 Trial in Russian Federation (Insulin Humulin® NPH, Insulin Rinsulin® NPH)
Completed
- Diabetes Mellitus, Type 2
- Insulin Humulin® NPH
- Insulin Rinsulin® NPH
-
Chelyabinsk, Russian Federation
- +13 more
Jul 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Buenos Aires, Argentina
- +140 more
May 28, 2019
Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)
Diabetes, Type 2, Diabetes Complications Trial in Moscow (Cocarnit)
Completed
- Diabetes Mellitus, Type 2
- Diabetes Complications
- Cocarnit
-
Moscow, Russian FederationInstitute for Atherosclerosis Research
Mar 19, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Concord, California
- +96 more
Mar 6, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +2 more
-
Glendale, Arizona
- +143 more
Jan 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Fresno, California
- +90 more
Dec 7, 2018
Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed
- Diabetes
- +2 more
- No treatment given
-
Prov. De Buenos Aires, Argentina
- +23 more
Dec 7, 2018
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018
Diabetes, Type 2 Trial in Worldwide (SRT2104, Placebo)
Diabetes, Type 2 Trial in Worldwide (LY2605541, insulin glargine)
Completed
- Diabetes Mellitus, Type 2
- LY2605541
- insulin glargine
-
Idaho Falls, Idaho
- +24 more
May 4, 2018
Diabetes, Type 2 Trial in Worldwide (LY2605541, Insulin Glargine, Insulin Lispro)
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Tuscumbia, Alabama
- +116 more
Mar 1, 2018